Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

QUINIDINE GLUC ER 324 MG TAB

Quinidine gluonate
$5.8255per EA

Strength

324 mg/1

Manufacturer

Eywa Pharma Inc

NDC

71930001612

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

QUINIDINE GLUCONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212589

On Market Since

3/20/2022

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 2D6 Inhibitor
Cytochrome P450 2D6 Inhibitors

Price History

1W

0.0%

1M

-3.6%

3M

+1.5%

6M

+13.2%

1Y

+1.6%

3Y

N/A

5Y

N/A

All

-9.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0283
per GM
SERTRALINE HCL 25 MG TABLET
Generic
00904692461•Major Pharmaceuticals
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061101•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061104•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061105•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061106•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021515•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021516•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075705•Heritage Pharmaceuticals Inc.
$0.0300
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy